NIH-funded research NIH-funded research

Harmful gut bacteria linked to alcohol-related liver damage

Official title: The role of pathobionts in alcoholic liver disease

Funded at VA San Diego Healthcare System · NIH-11212762 · Data updated 2026-11-12

This work looks at whether certain harmful gut bacteria make liver disease worse in people who drink heavily.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA San Diego Healthcare System
NIH-funded
Lab location1 site (San Diego, United States)
Project startOctober 1, 2018
Project endSeptember 30, 2030
Funding year2026
NIH project number5I01BX004594-08
Project IDNIH-11212762 on NIH RePORTER

Who could benefit from this research

Could help

Adults with alcohol use disorder or alcoholic hepatitis, particularly Veterans receiving care at the San Diego VA who can provide stool and blood samples, are the most suitable candidates.

Less likely to help

People without alcohol-related liver disease or whose liver problems arise from unrelated causes are unlikely to benefit directly from this research.

What this research studies

Researchers compare gut bacteria in stool from people with alcoholic hepatitis, people with alcohol use disorder, and people without liver disease using metagenomic sequencing. They focus on an E. coli gene called kpsM that helps the bacteria hide from liver immune cells and has been linked to worse outcomes. Lab experiments study how kpsM-positive E. coli interacts with liver immune cells and use germ-free mice given patient stool to see if those bacteria worsen alcohol-related liver injury. If you join, you may be asked to provide stool and clinical samples to help link your gut microbes to liver inflammation.

Why it matters

Potential benefit: If successful, this work could point to new treatments that target harmful gut bacteria to reduce liver inflammation and improve outcomes for people with alcohol-related liver disease.

How similar studies have gone: Other studies have connected microbiome changes to alcoholic liver disease and animal work supports a bacterial role, but targeting specific bacterial virulence genes like kpsM is a more recent and less-tested approach.

Where this research is happening

  • VA San Diego Healthcare System
    San Diego, United States
    Active

Researchers

  • Principal investigator: Schnabl, Bernd G. — VA San Diego Healthcare System
  • Study coordinator: Schnabl, Bernd G.

Related research

Other NIH-funded projects on the same topics.

  • Microbiome and Innate Immune Response in Alcohol-Related Liver Disease

    Researchers are studying how gut bacteria and the body's first-line immune defenses contribute to liver damage from alcohol, with a focus on how a specific bacteria and its toxins affect disease severity.

    NIH research University of California, San Diego · La Jolla, United States · NIH-11543368

  • Lipotoxicity and Alcohol-Related Liver Disease

    This project studies how fatty acids cause liver cell damage in alcohol-related liver disease to help develop new treatments.

    NIH research University of North Carolina Greensboro · Greensboro, United States · NIH-11450399

  • NNMT as a Target to Treat Alcoholic Liver Disease

    A study to see if blocking an enzyme called NNMT can help people with alcoholic liver disease.

    NIH research University of Illinois at Chicago · Chicago, UNITED STATES · NIH-11380807

  • How gut fungi may drive alcohol-related liver damage

    Researchers are looking at whether specific fungi in the gut make liver damage from heavy drinking worse in people with alcohol-related liver disease.

    NIH research University of California, San Diego · La Jolla, United States · NIH-11378956

  • Heat shock protein 90 and alcohol-related liver disease: how macrophages fuel inflammation

    This project looks at how a cellular stress protein, HSP90, affects liver inflammation in people with alcohol-related liver disease by focusing on macrophages.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11374847

  • Why alcohol-related liver disease can come back after a transplant

    Looking at whether an enzyme called CerS6 helps fat build up in the liver and whether measuring CerS6 can help detect or predict return of alcohol-related liver disease before or after a liver transplant.

    NIH research University of Washington · Seattle, United States · NIH-11329541

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.